T-cell response to 3 doses of Sars-Cov2 BNT162b2 Pfizer vaccine in long term rituximab treated patients.

ABSTRACT:

SUBMITTER: Heitz J 

PROVIDER: S-EPMC8784462 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature